<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><?release-delay 0|0 ?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="hwp">jbc</journal-id><journal-id journal-id-type="pmc">jbc</journal-id><journal-id journal-id-type="publisher-id">JBC</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name><publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3057819</article-id><article-id pub-id-type="publisher-id">M110.165274</article-id><article-id pub-id-type="doi">10.1074/jbc.M110.165274</article-id><article-categories><subj-group subj-group-type="heading"><subject>Membrane Biology</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="7527" pm="."><plain>Activation of Colicin M by the FkpA Prolyl Cis-Trans Isomerase/Chaperone* </article-title><alt-title alt-title-type="short">Cma Activation by FkpA</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Helbig</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Patzer</surname><given-names>Silke I.</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schiene-Fischer</surname><given-names>Cordelia</given-names></name><xref ref-type="aff" rid="aff2"><sup>§</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zeth</surname><given-names>Kornelius</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref></contrib><contrib contrib-type="author"><name><surname>Braun</surname><given-names>Volkmar</given-names></name><xref ref-type="aff" rid="aff1"><sup>‡</sup></xref><xref ref-type="corresp" rid="cor1"><sup>1</sup></xref></contrib><aff id="aff1">From the <label>‡</label>Max Planck Institute for Developmental Biology, Spemannstrasse 35, 72076 Tübingen, Germany and </aff><aff id="aff2">the <label>§</label>Max Planck Research Unit of Enzymology of Protein Folding, 06120 Halle, Germany</aff></contrib-group><author-notes><corresp id="cor1"><label>1</label> To whom correspondence should be addressed. Tel.: <phone>49-7071-601343</phone>; Fax: <fax>49-7071-601349</fax>; E-mail: <email>volkmar.braun@tuebingen.mpg.de</email>.</corresp></author-notes><pub-date pub-type="ppub"><day>25</day><month>2</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2010</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>12</month><year>2010</year></pub-date><volume>286</volume><issue>8</issue><fpage>6280</fpage><lpage>6290</lpage><history><date date-type="received"><day>19</day><month>7</month><year>2010</year></date><date date-type="rev-recd"><day>12</day><month>11</month><year>2010</year></date></history><permissions><copyright-statement>© 2011 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement><license license-type="open-access"><license-p><italic>Author's Choice</italic>—Final version full access.</license-p><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non-Commercial License</ext-link> applies to Author Choice Articles</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zbc00811006280.pdf"/><abstract><p><SecTag type="ABS"><text><SENT sid="7528" pm="."><plain>Colicin M (Cma) is specifically imported into the periplasm of Escherichia coli and kills the cells. Killing depends on the periplasmic peptidyl prolyl cis-trans isomerase/chaperone FkpA. To identify the Cma prolyl bonds targeted by FkpA, we replaced the 15 proline residues individually with alanine. Seven mutant proteins were fully active; Cma(P129A), Cma(P176A), and Cma(P260A) displayed 1%, and Cma(P107A) displayed 10% of the wild-type activity. Cma(P107A), Cma(P129A), and Cma(P260A), but not Cma(P176A), killed cells after entering the periplasm via osmotic shock, indicating that the former mutants were translocation-deficient; Cma(P129A) did not bind to the FhuA outer membrane receptor. The crystal structures of Cma and Cma(P176A) were identical, excluding inactivation of the activity domain located far from Pro-176. </plain></SENT>
<SENT sid="7534" pm="."><plain>In a new peptidyl prolyl cis-trans isomerase assay, FkpA isomerized the Cma prolyl bond in peptide Phe-Pro-176 at a high rate, but Lys-Pro-107 and Leu-Pro-260 isomerized at only &lt;10% of that rate. The four mutant proteins secreted into the periplasm via a fused signal sequence were toxic but much less than wild-type Cma. Wild-type and mutant Cma proteins secreted or translocated across the outer membrane by energy-coupled import or unspecific osmotic shock were only active in the presence of FkpA. We propose that Cma unfolds during transfer across the outer or cytoplasmic membrane and refolds to the active form in the periplasm assisted by FkpA. Weak refolding of Cma(P176A) would explain its low activity in all assays. Of the four proline residues identified as being important for Cma activity, Phe-Pro-176 is most likely targeted by FkpA. </p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Bacterial Toxins</kwd><kwd>Chaperone Chaperonin</kwd><kwd>Membrane Proteins</kwd><kwd>Protein Structure</kwd><kwd>Protein Translocation</kwd><kwd>Colicin</kwd><kwd>FkpA</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro"><title><text><SENT sid="7540" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="7541" pm="."><plain>Colicin M (Cma)2 is synthesized by Escherichia coli cells that carry a pColBM plasmid and is unspecifically released to a low extent. It kills sensitive E. coli cells by interfering with lipid carrier recycling, leading to inhibition of murein biosynthesis and cell lysis (1, 2). </plain></SENT>
<SENT sid="7543" pm="."><plain>Specifically, Cma cleaves the phosphate ester bond between the lipid carrier (bactoprenol) and the murein precursor (3). </plain></SENT>
<SENT sid="7544" pm="."><plain>Cma enters the periplasm of sensitive cells by binding to the FhuA outer membrane receptor protein and translocation across the outer membrane by an energy-coupled mechanism through the action of the TonB, ExbB, and ExbD proteins (Ton system) (4–6). <p><text><SENT sid="7545" pm="."><plain>Like all colicins, Cma consists of a central receptor binding domain, an N-terminal translocation domain, and a C-terminal activity domain (7), which can be seen in the crystal structure (8). </plain></SENT>
<SENT sid="7546" pm="."><plain>Only the activity domain, which starts at residue 124, is homologous with colicin-M-like proteins of other bacteria (8, 9). <p><text><SENT sid="7547" pm="."><plain>The first E. coli mutants identified that were resistant to added colicin M were mutated in the fhuA, tonB, exbB, or exbD transport genes. Another type of Cma-resistant mutant eluded genetic and function characterization (10) until recently. We localized the mutation to the fkpA gene, which encodes a periplasmic peptidyl prolyl cis-trans isomerase (PPIase)/chaperone. Among 10 colicins tested, only Cma requires FkpA for toxicity (11). <p><text><SENT sid="7551" pm="."><plain>The function of FkpA for E. coli physiology, however, is not clear as fkpA mutants show no phenotype. FkpA is overexpressed under stress conditions, partially controlled by σE through a σE promoter. Deletion of fkpA stimulates transcription of degP, which encodes a heat shock-inducible periplasmic protease (12). </plain></SENT>
<SENT sid="7554" pm="."><plain>Overproduction of FkpA prevents the formation of periplasmic inclusion bodies of MalE31, a defective folding derivative of the MalE-binding protein (13), and increases the yield of functional engineered antibody fragments produced in E. coli (14). <p><text><SENT sid="7555" pm="."><plain>FkpA displays high PPIase activity, as demonstrated by the refolding of ribonuclease T1 and prolyl cis-trans isomerization of oligopeptides (15). </plain></SENT>
<SENT sid="7556" pm="."><plain>Its activity is inhibited by FK506, an inhibitor of prokaryotic and eukaryotic FKBP-type PPIases (15). </plain></SENT>
<SENT sid="7557" pm="."><plain>FkpA forms a dimer; the monomers consist of an N-proximal helical domain (residues 1–114) and a C-proximal domain (residues 115–245) typical for the FKBP family of PPIases (16). </plain></SENT>
<SENT sid="7558" pm="."><plain>The five periplasmic PPIases/chaperones PpiA, PpiD, SurA, FkpA, and Skp usually act on various substrates and can functionally replace each other (17–19). </plain></SENT>
<SENT sid="7559" pm="."><plain>In contrast, the toxicity of Cma strictly depends on FkpA and not on any other E. coli PPIase/chaperone (11). <p><text><SENT sid="7560" pm="."><plain>The strict dependence of Cma toxicity on FkpA prompted us to attempt to identify the prolyl bond targeted by FkpA. If periplasmic Cma activity depends on the FkpA prolyl cis-trans isomerase function and not, or not only on the FkpA chaperone function, replacement of the proline residue that is cis-trans-isomerized should prevent activation. To test this premise we replaced each of the 15 proline residues in Cma individually with alanine. Here we identified one prolyl bond that could serve as the target of FkpA PPIase catalysis. </sec></SecTag><SecTag type="METHODS"><sec sec-type="methods"><title><text><SENT sid="7564" pm="."><plain>EXPERIMENTAL PROCEDURES </plain></SENT>
</text></title><sec><title/><sec><title/><sec><title><text><SENT sid="7565" pm="."><plain>Bacterial Strains and Plasmids </plain></SENT>
</text></title><p><text><SENT sid="7566" pm="."><plain>The bacterial strains and plasmids used and their sources are listed in Table 1. </plain></SENT>
<SENT sid="7567" pm="."><plain>Isolation of the FkpA313 mutant SIP1275 and the temperature-sensitive FkpA43 mutant K458 was described previously (10, 11, 20). <SecTag type="TABLE"><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p><text><SENT sid="7568" pm="."><plain>E. coli strains and plasmids used in this study </caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="7569" pm="."><plain>Strain/Plasmid </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7570" pm="."><plain>Genotype </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7571" pm="."><plain>Reference </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7572" pm="."><plain>Strain </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7573" pm="."><plain>    AB2847 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7574" pm="."><plain>aroB thi tsx malT </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7575" pm="."><plain>(1) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7576" pm="."><plain>    BL21(DE3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7577" pm="."><plain>F−ompT gal dcm lon hsdB (rB− mB−) λ(DE3) lacI lacUV5-T7 gene 1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7578" pm="."><plain>(50) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7579" pm="."><plain>    BL21 fhuA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7580" pm="."><plain>BL21(DE3) fhuA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7581" pm="."><plain>(11) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7582" pm="."><plain>    MB97 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7583" pm="."><plain>AB2847 ΔfhuA </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7584" pm="."><plain>(54) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7585" pm="."><plain>    K458 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7586" pm="."><plain>AB2847 fkpA43 (tolM-ts) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7587" pm="."><plain>(20) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7588" pm="."><plain>    Mo3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7589" pm="."><plain>AB2847 fkpA40 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7590" pm="."><plain>(10) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7591" pm="."><plain>    ES965 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7592" pm="."><plain>KTu50 pES7 cba cbi on pACYC184 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7593" pm="."><plain>(51) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7594" pm="."><plain>    DH5α </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7595" pm="."><plain>supE44 ΔlacU169 [Φ80lacZΔM15] hsdR17 recA1 endA1 gyrA thi-1 relA1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7596" pm="."><plain>(52) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7597" pm="."><plain>    SIP1275 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7598" pm="."><plain>AB2847 fkpA313 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7599" pm="."><plain>(11) </plain></SENT>
</text></td></tr><tr><td colspan="3" rowspan="1"><text><SENT sid="7600" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7601" pm="."><plain>Plasmid </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7602" pm="."><plain>    pMLD237 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7603" pm="."><plain>cma encoding Cma-Hisa </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7604" pm="."><plain>(3) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7605" pm="."><plain>    pSP127/56 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7606" pm="."><plain>pET25b encoding FkpA313-Hisb </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7607" pm="."><plain>(11) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7608" pm="."><plain>    pYH15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7609" pm="."><plain>pET25b encoding FkpA-Hisb </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7610" pm="."><plain>(11) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7611" pm="."><plain>    pYH16 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7612" pm="."><plain>pET25b encoding FkpA43-Hisb </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7613" pm="."><plain>(11) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7614" pm="."><plain>    pGP1–2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7615" pm="."><plain>Gene 1 (T7 polymerase) behind λPL controlled by the temperature-sensitive CI857 λ repressor </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7616" pm="."><plain>(53) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7617" pm="."><plain>    pPG773 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7618" pm="."><plain>pT7–7 pbpB-cmi, ApR encoding PbpB′-′Cmi </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7619" pm="."><plain>(33) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7620" pm="."><plain>    pSP130/155 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7621" pm="."><plain>encodes MalE1–26-Cma1–271 with a C-terminal His-tag controlled by the araBAD promoter, araC, Apr </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7622" pm="."><plain>This study </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="TF1-1"><p><text><SENT sid="7623" pm="."><plain>a Cma with a N-terminal His6 tag. </fn><fn id="TF1-2"><p><text><SENT sid="7624" pm="."><plain>b FkpA protein with a C-terminal His6 tag. </fn></table-wrap-foot></table-wrap></SecTag></sec><sec><title><text><SENT sid="7625" pm="."><plain>Generation of Cma Proline Substitution Mutants </plain></SENT>
</text></title><p><text><SENT sid="7626" pm="."><plain>The cma gene on plasmid pMLD237 (generously provided by D. Mengin-Lecreulx, Université Paris-Sud, Orsay, France) encodes Cma with an N-terminal His6 tag. We replaced each of the 15 proline residues in Cma with alanine by site-directed mutagenesis of cma with appropriate primers (sequences available upon request) using the QuickChange® site-directed mutagenesis kit (Stratagene, La Jolla, CA) and the PhusionTM high fidelity DNA polymerase (Finnzymes, Espoo, Finland). </plain></SENT>
<SENT sid="7629" pm="."><plain>Mutagenized cma genes on plasmid pMLD237 were introduced into E. coli DH5α by transformation, and the mutations were verified by sequencing the cma genes isolated from the transformants. Cma activity was determined with transformants of E. coli BL21 fkpA carrying the mutated cma genes on pMLD237. </plain></SENT>
<SENT sid="7631" pm="."><plain>For the assay, crude cell extracts were serially diluted 10-fold, and 10 μl were spotted on LB agar plates seeded with E. coli AB2847. </plain></SENT>
<SENT sid="7632" pm="."><plain>The same procedure was used to isolate the mutant Cma(D226A). <p><text><SENT sid="7633" pm="."><plain>To equip Cma with a signal sequence, cma on pMLD237 was amplified by PCR, ligated to a sequence encoding a C-terminal His-tag, and cloned downstream of malE′ of pMA-RQ MalE′-Cma1–130 synthesized by Geneart (Regensburg, Germany), replacing cma1–130. </plain></SENT>
<SENT sid="7634" pm="."><plain>The resulting plasmid pSP130/155 encodes the signal sequence MalE1–26 (Swissprot P0AEX9), Cma1–271 (Swissprot P05820) and the C-terminal His-tag LAHHHHHH under the control of the araBAD promoter. The plasmid contains araC from pMA-RQ MalE′-Cma(1–130). </plain></SENT>
<SENT sid="7636" pm="."><plain>pSP130/155 was mutagenized by site-directed mutagenesis, resulting in plasmids encoding MalE′-Cma(P107A)-His, MalE′-Cma(P129A)-His, MalE′-Cma(P176A)-His, MalE′-Cma(D226A)-His, and MalE′-Cma(P260A)-His. </sec><sec><title><text><SENT sid="7637" pm="."><plain>Isolation of Cma and Mutant Cma </plain></SENT>
</text></title><p><text><SENT sid="7638" pm="."><plain>Cma and the proteins from transformants of E. coli BL21(DE3) fkpA harboring the recombinant plasmids were purified on Ni-NTA-agarose as described previously (11), taking advantage of the His6 tag on the proteins. E. coli BL21(DE3) fkpA is not killed by Cma because of the fkpA mutation. </sec><sec><title><text><SENT sid="7639" pm="."><plain>Isolation of Colicin B and Competition Assays </plain></SENT>
</text></title><p><text><SENT sid="7640" pm="."><plain>A crude extract of colicin B was isolated from E. coli ES965 (pES7 cba cbi). </plain></SENT>
<SENT sid="7641" pm="."><plain>Synthesis of colicin B was induced by adding 0.4 μg ml−1 mitomycin C in water to the culture and shaking the culture for 150 min at 37 °C. Cells were harvested and suspended in 0.1 m Tris-HCl, pH 7.5, and disrupted by sonication, and the suspension was centrifuged. The soluble fraction containing colicin B was active up to a dilution of 106 and was used for competition assays with Cma and the nearly inactive Cma proline mutants. For the assays, exponentially growing cells of E. coli Mo3 fkpA40 were supplemented with a Cma sample and incubated for 10 min; colicin B at a final dilution titer of 104 was then added. Growth of the cultures was monitored spectrophotometrically for 5 h. </sec><sec><title><text><SENT sid="7646" pm="."><plain>Isolation of FkpA-His6 </plain></SENT>
</text></title><p><text><SENT sid="7647" pm="."><plain>FkpA-His6 was isolated from cells of E. coli BL21(DE3) fkpA transformed with pYH15 fkpA and purified on Ni-NTA-agarose as described (11). </plain></SENT>
<SENT sid="7648" pm="."><plain>The eluate of the column was concentrated with Amicon ultra-15 tubes, and FkpA was further purified by chromatography on a 320-ml Superdex 75 column with 35 mm HEPES, pH 7.8. </plain></SENT>
<SENT sid="7649" pm="."><plain>The presence of the desired proteins and impurities in the eluted fractions were analyzed by SDS-PAGE. FkpA313-His and FkpA43-His from cells transformed with plasmids pSP127/56 and pYH16, respectively, were isolated accordingly to electrophoretic homogeneity. </sec><sec><title><text><SENT sid="7651" pm="."><plain>Crystallization, Data Collection, Phasing, and Refinement </plain></SENT>
</text></title><p><text><SENT sid="7652" pm="."><plain>Crystallization of initial protein crystals were obtained by sitting-drop crystallization with screens purchased from Qiagen mixing 0.4 μl of protein with 0.4 μl of reservoir solution. Drops were prepared using the Honeybee 961 crystallization robot (Genomic Solutions) and automatically imaged using the Rock Imager 54 imaging system (Formulatrix, Waltham). </plain></SENT>
<SENT sid="7654" pm="."><plain>Crystals of wild-type (wt) and mutant proteins were mounted from the crystallization drops and frozen in liquid nitrogen according to the procedure described in Table 3. </plain></SENT>
<SENT sid="7655" pm="."><plain>Data of wt and mutant crystals were collected either at beamline PXII, Swiss Light Source, or beamline ID29 of the European Synchrotron Radiation Facility. Diffraction images were recorded on the detector types mentioned in Table 3. </plain></SENT>
<SENT sid="7657" pm="."><plain>All diffraction images were processed and scaled with the XDS/XCALE program package (21). </plain></SENT>
<SENT sid="7658" pm="."><plain>The structure of the wt crystals was solved by molecular replacement using the MOLREP program starting from the PDB entry <ext-link ext-link-type="pdb" xlink:href="3DA4">3DA4</ext-link> (MOLREP). </plain></SENT>
<SENT sid="7659" pm="."><plain>Structures of the two mutant datasets were solved using the wt structure and the program MOLREP. Model building and refinement of all structures was performed in CCP4i (22) and Coot (23). </plain></SENT>
<SENT sid="7661" pm="."><plain>Protein geometry was analyzed using the program PROCHECK (24), and secondary structures were assigned based on the DSSP algorithm (25). </plain></SENT>
<SENT sid="7662" pm="."><plain>All pictures were prepared using the PYMOL program. Statistics are summarized in Table 3. </sec><sec><title><text><SENT sid="7664" pm="."><plain>Cma Sensitivity Tests </plain></SENT>
</text></title><p><text><SENT sid="7665" pm="."><plain>Sensitivity of E. coli cells to Cma was tested with Cma, and mutant derivatives were purified to electrophoretic homogeneity by Ni-NTA-agarose chromatography or with crude extracts of cells that overexpressed Cma or mutant derivatives. In the latter case the Cma protein was by far the most prominent protein in the cell extract, as revealed by SDS-PAGE. The cma transformants released less than 10% of the Cma produced as they lack a Cma lysis gene, which is also absent on natural pColBM plasmids (26). </plain></SENT>
<SENT sid="7668" pm="."><plain>Cells from an 8-ml culture were harvested by centrifugation and suspended in 0.5 ml of 0.1 m Tris-HCl, pH 7.5. </plain></SENT>
<SENT sid="7669" pm="."><plain>An aliquot of 0.2 ml was disrupted by vigorously shaking with glass beads, and cell debris was removed by centrifugation (16,000 × g, 4 °C). </plain></SENT>
<SENT sid="7670" pm="."><plain>10-Fold dilutions of Cma were spotted onto 20 ml of LB agar plates seeded with 109 cells of the strains to be tested in 3 ml of soft agar. The results are given as the diameter (in mm) of the clear zone of growth inhibition. <p><text><SENT sid="7672" pm="."><plain>To examine the sensitivity of cells overexpressing FkpA, we used E. coli BL21(DE3) fkpA transformed with both pYH15 fkpA and pGP1-2, which encodes the T7 polymerase gene 1 behind λPL, controlled by the temperature-sensitive CI857 λ repressor. Cells were grown at 30 °C to an A578 nm of 0.3 and then shifted for 150 min to 42 °C. 10-Fold-diluted Cma samples were spotted onto LB plates seeded with temperature-induced E. coli BL21(DE3) fkpA (pYH15 fkpA pGP1-2) and incubated overnight at 37 °C. The diameter of the lysis zone was measured. </sec><sec><title><text><SENT sid="7676" pm="."><plain>Osmotic Shock </plain></SENT>
</text></title><p><text><SENT sid="7677" pm="."><plain>Osmotic shock not only releases periplasmic proteins into the shock medium (27) but also transfers added proteins into the periplasm (10, 28, 29). </plain></SENT>
<SENT sid="7678" pm="."><plain>The Cma sensitivity of cells after osmotic shock was tested with purified Cma samples. <p><text><SENT sid="7679" pm="."><plain>E. coli AB2847 in 10 ml of LB medium was grown to an A578 nm of 0.5; cells were harvested by centrifugation and then suspended in 1 ml of 10 mm Tris-HCl, 30 mm NaCl, pH 7 (buffer 1). </plain></SENT>
<SENT sid="7680" pm="."><plain>Cells were pelleted by centrifugation, washed once with buffer 1, and centrifuged again. The washed cells were suspended in 0.5 ml of 33 mm Tris-HCl, pH 7 (buffer 2), and 0.1-ml aliquots were added to four tubes. Sucrose (40% in buffer 2, 0.1 ml) was added to two tubes, and buffer 2 (0.1 ml) was added to the other two tubes. Cells were suspended by vortexing, kept for 10 min on a shaker, then cooled from room temperature to 4 °C and harvested by centrifugation. Cma (10 μg in 10 μl) was added to an Eppendorf tube containing a cell suspension treated with sucrose and a tube containing an untreated cell suspension. Then 0.2 ml of ice-cold 0.5 mm MgCl2 and 30 μl of 1 mm CaCl2 was added to each tube; the in vivo activity of Cma depends on Ca2+ (20). </plain></SENT>
<SENT sid="7686" pm="."><plain>The contents of the tubes were immediately mixed by vortexing. Two additional samples received no Cma but were otherwise treated the same way. The four samples were kept on ice for 15 min and then serially diluted 10-fold in buffer 2. </plain></SENT>
<SENT sid="7689" pm="."><plain>Aliquots of 0.1 ml were suspended in 3 ml of LB soft agar and spread on 20-ml LB agar plates. After overnight incubation at 37 °C, the colonies were counted. </sec><sec><title><text><SENT sid="7691" pm="."><plain>Activity Assay for Secreted Cma </plain></SENT>
</text></title><p><text><SENT sid="7692" pm="."><plain>Cells containing wild-type cma and cma mutant genes fused to the MalE signal sequence were grown in LB medium containing ampicillin to the exponential growth phase. Arabinose was added to the final concentrations indicated in Fig. 4. </plain></SENT>
<SENT sid="7694" pm="."><plain>To avoid killing of cells by Cma released into the medium, transformants of the fhuA mutant MB97 were used. In the case of fkpA mutants this precaution was not required as they are resistant to Cma. Cell growth and lysis were monitored by measuring the optical density at 578 nm. </sec><sec><title><text><SENT sid="7697" pm="."><plain>Determination of PPIase Activity in Vitro </plain></SENT>
</text></title><p><text><SENT sid="7698" pm="."><plain>The cis-trans isomerization of the peptides p-aminobenzoyl-CFPVC-(NO2)Tyr-NH2 (P is Pro-176), p-aminobenzoyl-CKP)AC-(NO2)Tyr-NH2 (P is Pro-107), and p-aminobenzoyl-CLPGC-(NO2)Tyr-NH2 (P is Pro-260) was induced by reducing the disulfide bond with 50 mm DTT in 35 mm HEPES, pH 7.8. </plain></SENT>
<SENT sid="7699" pm="."><plain>The time course of fluorescence of 1 μm concentrations of each peptide at 10 °C was followed at 420 nm after the peptides were transferred from the peptide stock solution in DMSO to the final buffer solution. The excitation wavelength was 320 nm, and the spectral bandwidth was 5 nm. Data were analyzed by single exponential nonlinear regression using a Sigma Plot Scientific Graphing System. The samples contained 31–124 μm of FkpA and its derivatives. kcat/Km was determined by evaluating the linear dependence of kenz from the concentration of FkpA and its derivatives. kenz is the catalyzed first-order rate minus the uncatalyzed rate. kcat/Km was calculated from kenz/Eo, where Eo is the FkpA concentration. Each data point represents the mean of three independent measurements that differed less than 10%. </sec><sec><title><text><SENT sid="7704" pm="."><plain>Cleavage of Cma by Proteinase K </plain></SENT>
</text></title><p><text><SENT sid="7705" pm="."><plain>Cma and its derivatives tagged with His6 at the N terminus were purified on Ni-NTA-agarose; 20 μg of each protein was incubated with 0.01 μg of proteinase K for 13 min on ice and then analyzed by SDS-PAGE. </sec><sec><title><text><SENT sid="7706" pm="."><plain>Circular Dichroism (CD) </plain></SENT>
</text></title><p><text><SENT sid="7707" pm="."><plain>CD spectra of electrophoretically homogeneous wild-type and mutant Cma proteins were recorded in a Jasco spectral polarimeter model J-810 at 190–240 nm and 20 °C. Temperature-dependent denaturation was measured at 220 nm between 10 and 70 °C. </sec><sec><title><text><SENT sid="7709" pm="."><plain>Denaturation of Cma and Cma Mutants by Urea </plain></SENT>
</text></title><p><text><SENT sid="7710" pm="."><plain>Proteins (1 mg ml−1) dissolved in 20 mm potassium phosphate, 0.5 mm MgCl2, 2 mm mercaptoethanol, 150 mm NaCl, or in the same buffer containing 1–8 M urea were incubated for 15 min at 20 °C. The samples were centrifuged, and the fluorescence emission spectrum was measured between 300 and 500 nm (1 nm bandwidth), with excitation at 280 nm (3 nm bandwidth) in a Jasco spectrofluorometer FP-6500. </plain></SENT>
<SENT sid="7712" pm="."><plain>The values given are the average of five determinations. </sec></sec></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results"><title><text><SENT sid="7713" pm="."><plain>RESULTS </plain></SENT>
</text></title><sec><title/><sec><title/><sec><title><text><SENT sid="7714" pm="."><plain>Isolation of Pro → Ala Colicin M (Cma) Mutants </plain></SENT>
</text></title><p><text><SENT sid="7715" pm="."><plain>We previously have shown that FkpA is required for killing E. coli K-12 by Cma (11). </plain></SENT>
<SENT sid="7716" pm="."><plain>If periplasmic Cma activity depends on the FkpA prolyl cis-trans isomerase function and not, or not only on the FkpA chaperone function, replacement of the proline residue that is cis-trans-isomerized should prevent activation. To test this premise we replaced each of the 15 proline residues of Cma individually with alanine. The activities of the Cma mutant proteins encoded on pMLD237 were first tested with crude extracts of the E. coli pMLD237 transformant BL21(DE3) fkpA after IPTG induction of cma transcription. The fkpA mutation prevented the producer cells to be killed by Cma. In the crude extracts the mutant Cma was the dominant protein (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S1</ext-link>). </plain></SENT>
<SENT sid="7721" pm="."><plain>10-Fold dilutions of each mutant Cma protein sample were spotted on nutrient agar seeded with Cma-sensitive E. coli AB2847. </plain></SENT>
<SENT sid="7722" pm="."><plain>Four mutants (Cma(P9A), Cma(P11A), Cma(P28A), and Cma(P157A)) showed higher activities than wild-type Cma, and seven mutants had activities similar to that of the wild type (Table 2); these mutants were not studied further. Cma(P129A), Cma(P176A), and Cma(P260A) displayed 1% of the wild-type activity, and Cma(P107A) showed 10% of the wild-type activity (Table 2). </plain></SENT>
<SENT sid="7724" pm="."><plain>Samples of the Cma(P → A) double mutants Cma(P129A,P176A), Cma(P129A,P260A), and Cma(P176A,P260A) were completely inactive (data not shown). </plain></SENT>
<SENT sid="7725" pm="."><plain>The location of the P107A, P129A, P176A, and P260A mutations in the Cma crystal structure is shown in Fig. 1. <SecTag type="TABLE"><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p><text><SENT sid="7726" pm="."><plain>Activities of the Cma Pro → Ala mutants <p><text><SENT sid="7727" pm="."><plain>Clear zones of growth inhibition are listed. </caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="2" colspan="1"><text><SENT sid="7728" pm="."><plain>Cma </plain></SENT>
</text></th><th align="center" colspan="4" rowspan="1"><text><SENT sid="7729" pm="."><plain>Diameter of the lysis zones </plain></SENT>
</text></th></tr><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="7730" pm="."><plain>100 dilution </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7731" pm="."><plain>101 dilution </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7732" pm="."><plain>102 dilution </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7733" pm="."><plain>103 dilution </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><text><SENT sid="7734" pm="."><plain>mm </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7735" pm="."><plain>Wild-type </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7736" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7737" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7738" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7739" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7740" pm="."><plain>P9A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7741" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7742" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7743" pm="."><plain>9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7744" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7745" pm="."><plain>P11A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7746" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7747" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7748" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7749" pm="."><plain>9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7750" pm="."><plain>P16A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7751" pm="."><plain>14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7752" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7753" pm="."><plain>9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7754" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7755" pm="."><plain>P28A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7756" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7757" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7758" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7759" pm="."><plain>6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7760" pm="."><plain>P31A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7761" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7762" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7763" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7764" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7765" pm="."><plain>P35A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7766" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7767" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7768" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7769" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7770" pm="."><plain>P48A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7771" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7772" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7773" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7774" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7775" pm="."><plain>P70A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7776" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7777" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7778" pm="."><plain>7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7779" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7780" pm="."><plain>P94A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7781" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7782" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7783" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7784" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7785" pm="."><plain>P107A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7786" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7787" pm="."><plain>11 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7788" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7789" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7790" pm="."><plain>P109A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7791" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7792" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7793" pm="."><plain>8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7794" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7795" pm="."><plain>P129A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7796" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7797" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7798" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7799" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7800" pm="."><plain>P157A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7801" pm="."><plain>15 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7802" pm="."><plain>12 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7803" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7804" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7805" pm="."><plain>P176A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7806" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7807" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7808" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7809" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7810" pm="."><plain>P260A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7811" pm="."><plain>10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7812" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7813" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7814" pm="."><plain>0 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="FIG"><fig id="F1" position="float"><label>FIGURE 1.</label><caption><p><text><SENT sid="7815" pm="."><plain>Location of the mutations in the crystal structure of Cma studied here (8). The predicted structural and functional domains are indicated; orange, N-terminal translocation domain; blue, central receptor binding domain; magenta, C-terminal activity domain; side chains of Pro-107, Pro-129, Pro-176, Pro-260, and Asp-226, which were replaced by alanine in this study are marked green (C-atoms, blue (nitrogen), and red (oxygen). </caption><graphic xlink:href="zbc0111151010001"/></fig></SecTag><p><text><SENT sid="7816" pm="."><plain>To examine whether overproduction of FkpA increases the toxicity of the Cma(P → A) mutants, crude extracts of wild-type and the three Cma mutant proteins with the lowest activity were spotted onto nutrient agar plates seeded with E. coli AB2847 carrying in addition to chromosomal fkpA, also fkpA encoded on plasmid pYH15 and the temperature-inducible T7 RNA polymerase gene on plasmid pGP1-2. </plain></SENT>
<SENT sid="7817" pm="."><plain>The toxicity of each Cma protein for the FkpA-overproducing strain and for untransformed strain AB2847 was the same (data not shown), i.e. the amount of chromosomally encoded FkpA was sufficient to confer the respective sensitivity to Cma and its mutant derivatives. <p><text><SENT sid="7818" pm="."><plain>Replacement of Pro-129, Pro-176, and Pro-260 by glycine or serine instead of alanine resulted in mutants with activities similar to those of the P → A mutants (data not shown). </plain></SENT>
<SENT sid="7819" pm="."><plain>The higher flexibility of the glycine bonds did not facilitate restoration of the active Cma conformation after transfer across the outer membrane, and the similarity of serine in the hydrogen-bonded form to proline did not increase Cma activity provided the proline residues were essential for Cma phosphatase activity (see also “Discussion”). </plain></SENT>
<SENT sid="7820" pm="."><plain>In addition, Pro-176 was replaced by leucine, valine, tyrosine, phenylalanine, lysine, and aspartate. The Cma derivatives showed 1% in vivo activity on FkpA wild-type cells, except P176F and P176Y, which displayed 10% of Cma wild-type activity. The activity of all mutant Cma proteins was zero on FkpA mutant cells. <p><text><SENT sid="7823" pm="."><plain>FkpA is not required to produce an active Cma. The activity of wild-type Cma released into the medium or isolated from the cytoplasm is the same when it is produced in wild-type and fkpA mutant cells (11). </plain></SENT>
<SENT sid="7825" pm="."><plain>FkpA is only required after uptake of Cma into the periplasm. Nevertheless, we examined whether the low activity of the four Cma P → A mutants was altered when they were produced in E. coli BL21 FkpA+ cells carrying a fhuA mutation, which confers resistance to Cma. Killing E. coli AB2847 by the Cma mutant proteins synthesized in E. coli BL21 fhuA was the same (1 and 10% activity) as killing by the Cma mutant proteins synthesized in parallel by E. coli BL21 fkpA, i.e. lack of FkpA did not affect the activity of the Cma mutant proteins. </sec><sec><title><text><SENT sid="7828" pm="."><plain>Structural Properties of the Cma P → A Mutant Proteins/Crystal Structures of Cma(P107A) and Cma(P176A) </plain></SENT>
</text></title><p><text><SENT sid="7829" pm="."><plain>Because the reduction in toxicity of the four mutant proteins might be related to changes in the structures, we determined the crystal structures of Cma(P107A) and Cma(P176A). </plain></SENT>
<SENT sid="7830" pm="."><plain>We selected these two proteins because Pro-107 forms the only proline cis bond in the Cma structure (8), and as will be shown below, the Pro-176 bond is most likely a target of FkpA. Cma, Cma(P107A), and Cma(P176A) were expressed; the production of similar amounts of the almost inactive Cma derivatives and wild-type Cma indicated that replacement of the proline residues by alanine did not cause gross structural changes that affected the yield and activity of the proteins. We determined an improved structure of wild-type Cma under conditions slightly different from those previously used (8) to 1.67 Å (Fig. 2A). </plain></SENT>
<SENT sid="7833" pm="."><plain>The published structures of Cma (Ref. 8; PDB entries <ext-link ext-link-type="pdb" xlink:href="3DA4">3DA4</ext-link> and <ext-link ext-link-type="pdb" xlink:href="3DA3">3DA3</ext-link>) showed partial disorder, in particular in the flexible N-terminal domain, which is frequently not seen in colicin structures. The new wild-type structure, in contrast, showed an excellent defined structural homogeneity for all main and side-chain atoms (Fig. 2A). </plain></SENT>
<SENT sid="7835" pm="."><plain>We determined the crystal structures of mutants Cma(P107A) and Cma(P176A) to 2.3 Å (eight monomers in the asymmetric unit) and 2.15 Å (two monomers in the asymmetric unit), respectively. Crystallographic data are summarized in Table 3. </plain></SENT>
<SENT sid="7837" pm="."><plain>The root mean square deviation between the mutant (P107A and P176A) and the wild-type structures was 0.3 and 0.2 Å2, respectively, including all Cα-atoms of the molecule. <SecTag type="FIG"><fig id="F2" position="float"><label>FIGURE 2.</label><caption><p><text><SENT sid="7838" pm="."><plain>A, ribbon model representation of the newly determined Cma wt structure in a side view illustration (PDB <ext-link ext-link-type="pdb" xlink:href="2XMX">2XMX</ext-link>) is shown. The structure consists of three domains, the N-terminal translocation domain (in green; T), the intermediate receptor binding domain (blue; R), and the C-terminal activity domains (orange; R). </plain></SENT>
<SENT sid="7840" pm="."><plain>The secondary structure elements and N (NT) and C termini (CT) of the structure as well as the two residues mutated are marked accordingly (α1-α5, β1-β6, NT, CT, P107, P176). B, superposition of the three structures represented as ribbon models (PDB <ext-link ext-link-type="pdb" xlink:href="2XTR">2XTR</ext-link>). </plain></SENT>
<SENT sid="7841" pm="."><plain>The wt structure is color-coded in orange, the P107A mutant structure is in blue, and the P176A structure is in red. C, zoom into the region of the extended loop connecting the receptor binding and activity domain is shown. Wt and mutant structures are displayed in the same orientation and color-coded as in B, and adjacent residues of the mutant (P107A) are shown in ball-and-stick representation. D, close-up of the second mutation Pro-176 located in the β1-sheet of the protein is shown. wt and mutant structures are displayed in the same orientation and color coded as in B; adjacent residues of the P176A mutant are shown in a ball-and-stick representation. </caption><graphic xlink:href="zbc0111151010002"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="T3" position="float"><label>TABLE 3</label><caption><p><text><SENT sid="7844" pm="."><plain>Data collection and refinement statistics </caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"><text><SENT sid="7845" pm="."><plain>Cma(WT) </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7846" pm="."><plain>Cma(P107A) </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="7847" pm="."><plain>Cma(P176A) </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7848" pm="."><plain>Data collection </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7849" pm="."><plain>    Space group </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7850" pm="."><plain>C2221 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7851" pm="."><plain>P1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7852" pm="."><plain>C2221 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7853" pm="."><plain>    Cell dimensions </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7854" pm="."><plain>        a, b, c (Å) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7855" pm="."><plain>52.75, 115.10, 227.71 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7856" pm="."><plain>52.85, 63.11, 189.34 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7857" pm="."><plain>52.83, 114.77, 225.40 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7858" pm="."><plain>        α, β, γ (°) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7859" pm="."><plain>90 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7860" pm="."><plain>87.59, 82.17, 65.65 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7861" pm="."><plain>90 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7862" pm="."><plain>    Resolution (Å) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7863" pm="."><plain>48-1.67a (1.71-1.67) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7864" pm="."><plain>49-2.31 (2.37-2.30) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7865" pm="."><plain>47-2.14 (2.19-2.14) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7866" pm="."><plain>    Rsym or Rmerge </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7867" pm="."><plain>0.08 (0.57) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7868" pm="."><plain>0.09 (0.40) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7869" pm="."><plain>0.19 (0.82) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7870" pm="."><plain>    I/σI </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7871" pm="."><plain>14.2 (1.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7872" pm="."><plain>5.4 (1.7) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7873" pm="."><plain>9.2 (2.0) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7874" pm="."><plain>    Completeness (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7875" pm="."><plain>97.3 (83.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7876" pm="."><plain>89.5 (72.9) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7877" pm="."><plain>99.0 (94.2) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7878" pm="."><plain>    Redundancy </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7879" pm="."><plain>5.2 (3.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7880" pm="."><plain>1.7 (1.5) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7881" pm="."><plain>6.3 (4.9) </plain></SENT>
</text></td></tr><tr><td colspan="4" rowspan="1"><text><SENT sid="7882" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7883" pm="."><plain>Refinement </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7884" pm="."><plain>    Resolution (Å) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7885" pm="."><plain>48-1.67 (1.71-1.67) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7886" pm="."><plain>49-2.31 (2.37-2.31) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7887" pm="."><plain>47-2.14 (2.19-2.14) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7888" pm="."><plain>    No. reflections </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7889" pm="."><plain>73413 (5526) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7890" pm="."><plain>85754 (4514) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7891" pm="."><plain>36063 (1898) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7892" pm="."><plain>    Rwork/Rfree </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7893" pm="."><plain>0.16/0.20 (0.25/0.30) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7894" pm="."><plain>0.24/0.27 (0.31/0.33) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7895" pm="."><plain>0.18/0.24 (0.26/0.30) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7896" pm="."><plain>    No. atoms (all) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7897" pm="."><plain>4,733 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7898" pm="."><plain>17,005 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7899" pm="."><plain>4,376 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7900" pm="."><plain>        Protein (chains/residues) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7901" pm="."><plain>2/540 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7902" pm="."><plain>8/2160 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7903" pm="."><plain>2/540 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7904" pm="."><plain>        Ligands (nitrate/glycerol) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7905" pm="."><plain>3/4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="7906" pm="."><plain>1/0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7907" pm="."><plain>        Water </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7908" pm="."><plain>434 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7909" pm="."><plain>451 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7910" pm="."><plain>319 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7911" pm="."><plain>    B-Factors </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7912" pm="."><plain>        Protein </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7913" pm="."><plain>5.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7914" pm="."><plain>13 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7915" pm="."><plain>20.6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7916" pm="."><plain>        Ligands (nitrate/glycerol) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7917" pm="."><plain>20/23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="7918" pm="."><plain>34/- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7919" pm="."><plain>        Water </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7920" pm="."><plain>15.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7921" pm="."><plain>9.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7922" pm="."><plain>26.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7923" pm="."><plain>    Root mean square deviations </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7924" pm="."><plain>        Bond lengths (Å) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7925" pm="."><plain>0.027 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7926" pm="."><plain>0.016 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7927" pm="."><plain>0.023 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7928" pm="."><plain>        Bond angles (°) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7929" pm="."><plain>2.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7930" pm="."><plain>1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7931" pm="."><plain>2.0 </plain></SENT>
</text></td></tr><tr><td colspan="4" rowspan="1"><text><SENT sid="7932" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7933" pm="."><plain>Ramachandran statistics </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7934" pm="."><plain>    Residues in favored regions (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7935" pm="."><plain>532 (99.3) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7936" pm="."><plain>2123 (99) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7937" pm="."><plain>531 (99.1) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7938" pm="."><plain>    Residues in allowed region (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7939" pm="."><plain>3 (0.6) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7940" pm="."><plain>21 (1) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7941" pm="."><plain>5 (0.9) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7942" pm="."><plain>    Residues in outlier region (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7943" pm="."><plain>1 (0.2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7944" pm="."><plain>0 (0) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7945" pm="."><plain>0 (0) </plain></SENT>
</text></td></tr><tr><td colspan="4" rowspan="1"><text><SENT sid="7946" pm="."><plain> </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7947" pm="."><plain>Crystallization conditions </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7948" pm="."><plain>20% PEG 3350 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7949" pm="."><plain>20% PEG 3350 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7950" pm="."><plain>20% PEG 3350 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="7951" pm="."><plain>0.2 m NaNO3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7952" pm="."><plain>0.2 m NaNO3, 0.1 m Bis/Tris, pH 6.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7953" pm="."><plain>0.2 m NaNO3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="7954" pm="."><plain>    Cryo protectant added </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7955" pm="."><plain>10% PEG 400 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7956" pm="."><plain>10% PEG 400 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="7957" pm="."><plain>10% PEG 400 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="TF3-1"><p><text><SENT sid="7958" pm="."><plain>a Values in parentheses are for highest-resolution shell. </fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="7959" pm="."><plain>Superposition of the Cma wild-type and mutant protein structures revealed identical folding (Fig. 2B). </plain></SENT>
<SENT sid="7960" pm="."><plain>Analysis of the local environment of each mutation revealed that the Lys-Pro cis bond in wild-type Cma was converted to a Lys-Ala trans bond in Cma(P107A), which caused a local distortion of the loop region that connects the receptor binding and the activity domains (Fig. 2C). </plain></SENT>
<SENT sid="7961" pm="."><plain>The structural changes were confined to the region around Pro-107 and elicited no long range structural transitions up to the predicted active center around Asp-226 (Fig. 1) (8, 9, 29). </plain></SENT>
<SENT sid="7962" pm="."><plain>In contrast, the P176A mutation had no visible effect on the local backbone geometry of the β3 strand of Cma, as demonstrated in a section of Cma(P176A) overlaid by wild-type Cma (Fig. 2D). </plain></SENT>
<SENT sid="7963" pm="."><plain>The entire structures were almost identical, which indicates that no conformational change inactivated Cma(P176A). </sec><sec><title><text><SENT sid="7964" pm="."><plain>Structural Properties of the Cma P → A Mutant Proteins in Solution </plain></SENT>
</text></title><p><text><SENT sid="7965" pm="."><plain>Although the crystal structure of Cma(P176A) and most likely also of Cma(P107A) excluded structural alterations of the Cma activity domain as the cause of the low toxicity, we examined the structures of the three mutants with 1% wild-type activity in solution using proteinase K degradation, circular dichroism (CD), and tryptophan fluorescence spectroscopy after denaturation with urea. Cma(P107A) was not included in all assays because it displayed a Cma activity higher (10%) than that of the other mutant proteins (1%). <p><text><SENT sid="7967" pm="."><plain>We chose proteinase K cleavage conditions such that Cma was not completely digested; instead, fragments were formed, of which the 24-kDa fragment resulted from Cma truncation at the N terminus (7). </plain></SENT>
<SENT sid="7968" pm="."><plain>By analyzing the formation of this intermediary product instead of analyzing complete digestion, differences in the structure of Cma and its mutant forms should become more apparent. No differences in the cleavage pattern of wild-type Cma and the Cma mutants were observed (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S2</ext-link>). <p><text><SENT sid="7970" pm="."><plain>Next, we used CD spectroscopy to discern whether the mutant Cma proteins structurally differed from wild-type Cma. The far-UV CD spectra of the four Cma mutants and the Cma wild-type were the same at 20 °C (data not shown). </plain></SENT>
<SENT sid="7972" pm="."><plain>However, at higher temperatures, the CD spectra indicated that Cma(P107A) (Tm = 51.8 °C) and Cma(P129A) (Tm = 48.8 °C) denatured at a lower temperature than Cma (Tm = 55.8 °C), Cma(P176A) (Tm = 55.4 °C), and Cma(P260A) (Tm = 55.0 °C) (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S3</ext-link>). <p><text><SENT sid="7973" pm="."><plain>We furthermore examined structural changes in the mutant proteins by measuring the fluorescence of urea-denatured proteins. The fluorescence emission maximum shifted to the red from 320 to 355 nm for Cma(P107A) and Cma(P129A) between 4 and 5 m urea and for Cma(P176A), Cma(P260A), and wild-type Cma between 5 and 6 m urea (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S4</ext-link>). </plain></SENT>
<SENT sid="7975" pm="."><plain>The lower urea stability of Cma(P107A) and Cma(P129A) agrees with their lower stability at higher temperatures. </sec><sec><title><text><SENT sid="7976" pm="."><plain>Translocation of the Cma P → A Mutant Proteins Across the Outer Membrane </plain></SENT>
</text></title><p><text><SENT sid="7977" pm="."><plain>We examined whether the Cma P → A mutants were defective in binding to the FhuA receptor and in translocation across the outer membrane. Receptor binding was determined by competition of Cma with the antibiotic albomycin, which binds to the same FhuA receptor as Cma. E. coli Mo3 fkpA40 was used because the fkpA deletion confers resistance to Cma (11). </plain></SENT>
<SENT sid="7979" pm="."><plain>Growth inhibition was, therefore, confined to the action of albomycin. Albomycin inhibited growth of E. coli Mo3 (Fig. 3). </plain></SENT>
<SENT sid="7981" pm="."><plain>Wild-type Cma prevented growth inhibition by albomycin, as did Cma(P107A), Cma(P176A), and Cma(P260A). </plain></SENT>
<SENT sid="7982" pm="."><plain>These proteins probably interfered with binding of albomycin to FhuA. In contrast, Cma(P129A) failed to interfere with albomycin. The low activity of Cma(P129A), therefore, most likely results from poor binding to FhuA. <SecTag type="FIG"><fig id="F3" position="float"><label>FIGURE 3.</label><caption><p><text><SENT sid="7985" pm="."><plain>Binding of wild-type and mutant Cma proteins to the FhuA receptor in a competition assay with albomycin. Exponentially growing E. coli Mo3 fkpA40 in LB medium untreated (■) and treated with 1 μg ml−1 albomycin (▴), treated with 0.1 mg ml−1 wild-type Cma and albomycin (□), with mutant Cma(P107A) and albomycin (♢), with mutant Cma(P129A) and albomycin (●), with mutant Cma(P176A) and albomycin (○), and with mutant Cma(P260A) and albomycin (▵). </plain></SENT>
<SENT sid="7986" pm="."><plain>Growth was monitored spectrophotometrically. The arrows indicate the addition of the Cma samples and albomycin. </caption><graphic xlink:href="zbc0111151010003"/></fig></SecTag><p><text><SENT sid="7988" pm="."><plain>Cma and albomycin not only share the common FhuA receptor, but also both use the Ton system for uptake. It is unlikely that albomycin uptake was inhibited because uptake of Cma, and its derivatives used up TonB. TonB can simultaneously interact with several receptors without substantially decreasing their transport rate (30). </plain></SENT>
<SENT sid="7991" pm="."><plain>Reduction of the transport rate of a substrate was only observed after strong overexpression of another TonB-dependent transport system (30). </plain></SENT>
<SENT sid="7992" pm="."><plain>Nevertheless, we determined whether Cma(P176A) and Cma(P260A) interfered with the activity of the Ton system. The competition assay was done with colicin B instead of albomycin; colicin B binds to the FepA receptor and not to FhuA but uses the Ton system for uptake. The Cma P → A mutants did not reduce growth inhibition of the Cma-resistant fkpA mutant Mo3 by colicin B, which indicates that the Cma mutant proteins do not interfere with the Ton system step of albomycin uptake. Interference of Cma with the target site of albomycin is also excluded as albomycin inhibits the seryl-tRNA synthetase; Cma, on the other hand, cleaves the phosphate ester bond between bactoprenol and the murein precursor. </sec><sec><title><text><SENT sid="7996" pm="."><plain>Lack of Translocation Versus Lack of Phosphatase Activity </plain></SENT>
</text></title><p><text><SENT sid="7997" pm="."><plain>To differentiate between lack of translocation across the outer membrane and lack of phosphatase activity, we used an osmotic shock procedure. Transferring E. coli cells from a medium of high osmolarity to a medium of low osmolarity renders their outer membrane temporarily permeable to proteins. The procedure was developed and widely used to release periplasmic proteins from cells (27) but can also be used to introduce proteins into cells, as has been shown for colicin E3 (28) and Cma (7, 10, 29). </plain></SENT>
<SENT sid="8000" pm="."><plain>The uptake of Cma by osmotic shock bypasses the requirement for the FhuA outer membrane receptor protein and the energizing Ton system. A variation of this procedure (10) was recently used to differentiate between Cma uptake and activity mutants (9). </plain></SENT>
<SENT sid="8002" pm="."><plain>We purified wild-type and mutant proteins to electrophoretic homogeneity (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Fig. S2</ext-link>) and used the same amounts of protein in the osmotic shock experiments. Osmotic shock treatment rendered cells sensitive to Cma(P107A), Cma(P129A), and Cma(P260A) (0.03 or 0.04% survivors) and to Cma(P176A) but to a much lower extent (0.4% survivors) (Table 4). </plain></SENT>
<SENT sid="8004" pm="."><plain>Killing by Cma(P129A) after osmotic shock agrees with its inability to kill cells under normal conditions because of its failure to bind to FhuA, which is not required to enter osmotically shocked cells. Because Cma(P107A) and Cma(P260A) bound to FhuA but hardly killed cells under normal conditions and were able to kill osmotically shocked cells after being unspecifically translocated into the periplasm, the uptake of these mutant proteins across the outer membrane must be impaired after binding to FhuA. We conclude that Cma(P107A), Cma(P129A), and Cma(P260A) show low activities because they are poorly taken up into the periplasm. <SecTag type="TABLE"><table-wrap id="T4" position="float"><label>TABLE 4</label><caption><p><text><SENT sid="8007" pm="."><plain>Activity of selected Cma mutant proteins introduced into cells by osmotic shock <p><text><SENT sid="8008" pm="."><plain>The percent of surviving cells of AB2847, its fkpA40 derivative, and the pPG773 cmi transformant were determined by plating after treatment with purified Cma wt and Cma mutant proteins transferred into cells by osmotic shock (+ shock) or without shock treatment (− shock). </plain></SENT>
<SENT sid="8009" pm="."><plain>The average percentage of survivors of all experiments after shock treatment without Cma was 6.0. </caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="2" colspan="1"><text><SENT sid="8010" pm="."><plain>Conditions </plain></SENT>
</text></th><th align="center" colspan="3" rowspan="1"><text><SENT sid="8011" pm="."><plain>Surviving cells </plain></SENT>
</text></th></tr><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="8012" pm="."><plain>AB2847 </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8013" pm="."><plain>AB2847 fkpA </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8014" pm="."><plain>AB2847 pPG773 cmi </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td align="center" colspan="3" rowspan="1"><text><SENT sid="8015" pm="."><plain>Percent of input </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8016" pm="."><plain>Cma wt + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8017" pm="."><plain>0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8018" pm="."><plain>1.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8019" pm="."><plain>6.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8020" pm="."><plain>Cma wt − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8021" pm="."><plain>0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8022" pm="."><plain>93.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8023" pm="."><plain>97.4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8024" pm="."><plain>Cma(P107A) + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8025" pm="."><plain>0.03 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8026" pm="."><plain>1.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8027" pm="."><plain>8.8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8028" pm="."><plain>Cma(P107A) − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8029" pm="."><plain>1.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8030" pm="."><plain>91.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8031" pm="."><plain>93.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8032" pm="."><plain>Cma(P129A) + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8033" pm="."><plain>0.04 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8034" pm="."><plain>0.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8035" pm="."><plain>7.0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8036" pm="."><plain>Cma(P129A) − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8037" pm="."><plain>1.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8038" pm="."><plain>95.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8039" pm="."><plain>95.8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8040" pm="."><plain>Cma(P176A) + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8041" pm="."><plain>0.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8042" pm="."><plain>0.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8043" pm="."><plain>8.9 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8044" pm="."><plain>Cma(P176A) − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8045" pm="."><plain>9.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8046" pm="."><plain>90.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8047" pm="."><plain>97.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8048" pm="."><plain>Cma(P260A) + shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8049" pm="."><plain>0.03 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8050" pm="."><plain>0.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8051" pm="."><plain>5.8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8052" pm="."><plain>Cma(P260A) − shock </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8053" pm="."><plain>1.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8054" pm="."><plain>90.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8055" pm="."><plain>100 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="8056" pm="."><plain>Wild-type and mutant Cma proteins were osmotically shocked into an fkpA deletion mutant to test whether FkpA was only required for the energy-coupled transfer of Cma across the outer membrane or also required after unspecific transfer by osmotic shock. The Cma proteins were osmotically shocked into E. coli Mo3 fkpA40 under conditions identical to those for the fkpA wild-type strain. Killing of the fkpA mutant by wild-type Cma and the proline Cma mutant proteins was strongly reduced (Table 4), which shows that regardless of the route across the outer membrane (energy-coupled import or entry by osmotic shock) FkpA was required for wild-type and mutant Cma activity in the periplasm. The results also demonstrated the reliability of the osmotic shock procedure as the Cma activities specifically required FkpA. However, the Cma proteins displayed residual Cma activities; 0.2–1.8% survival compared with 6% survival after osmotic shock in the absence of the Cma proteins (Table 4). </plain></SENT>
<SENT sid="8061" pm="."><plain>After osmotic shock, a fraction of the Cma molecules was active in the absence of FkpA. <p><text><SENT sid="8062" pm="."><plain>This conclusion was further supported by comparison of the surviving fkpA mutant cells with cells that synthesize the Cmi colicin M immunity protein. Cmi renders cells resistant to imported Cma (31). </plain></SENT>
<SENT sid="8064" pm="."><plain>Cmi is located in the periplasm and anchored to the cytoplasmic membrane by its N-terminal hydrophobic sequence (32, 33). </plain></SENT>
<SENT sid="8065" pm="."><plain>Membrane fixation brings Cmi to the site where Cma cleaves its substrate and prevents release of Cmi by osmotic shock. We used the previously constructed plasmid pPG773, in which the translocation and membrane anchor of the penicillin-binding protein PBP3 was fused to the periplasmic activity domain of Cmi (33). </plain></SENT>
<SENT sid="8067" pm="."><plain>Transformants carrying this plasmid confer immunity without induction of T7 polymerase synthesis because it contains an E. coli polymerase promoter. Wild-type Cma and the Cma P → A mutant proteins were completely inactive on plates seeded with E. coli AB2847 pPG773 cmi. After osmotic shock, Cma and the Cma derivatives were inactive (Table 4). </plain></SENT>
<SENT sid="8070" pm="."><plain>The percentage of survivors (average 7%) was in the range of the survivors after osmotic shock treatment without Cma (6%). </plain></SENT>
<SENT sid="8071" pm="."><plain>This shows that the Cma proteins that entered cells by osmotic shock were completely inactivated by Cmi. The fraction of surviving cells into which Cma and the Cma derivatives entered via the normal, energy-coupled route was similar in the fkpA mutant and the cmi transformants (92 and 100%, respectively; Table 4). </plain></SENT>
<SENT sid="8073" pm="."><plain>The almost complete resistance of the fkpA mutant to Cma and its mutant derivatives that enter the cell by energy-coupled uptake (− shock in Table 4) and the partial sensitivity of the fkpA mutant when Cma and its mutant derivatives are osmotically shocked into the cell support the conclusion that a fraction of Cma osmotically shocked into cells is active in the absence of FkpA. This fraction assumes an active conformation without the assistance of FkpA. <p><text><SENT sid="8075" pm="."><plain>Cma(P176A) differed from the other Cma P → A mutants in that its low activity after osmotic shock did not differ in wild-type and fkpA cells (0.4 versus 0.6% survivors). </plain></SENT>
<SENT sid="8076" pm="."><plain>The percentage of survivors of the immune cells treated with Cma(P176A) reached the level obtained with wild-type Cma and the other Cma P → A mutant proteins (Table 4). </plain></SENT>
<SENT sid="8077" pm="."><plain>This suggests that the residual activity of Cma(P176A) in Cmi-deficient cells is Cma-specific. <p><text><SENT sid="8078" pm="."><plain>The number of survivors in the control of the osmotic shock procedure, i.e. without osmotic shock treatment (Table 4), cannot be quantitatively compared with the number of survivors obtained by the plate test (Table 2). </plain></SENT>
<SENT sid="8079" pm="."><plain>In the osmotic shock procedure, test cells are exposed to Cma for 15 min at 4 °C, diluted, and then plated; in the plate test, cells are exposed to Cma overnight at 37 °C. </sec><sec><title><text><SENT sid="8080" pm="."><plain>Killing of Cells by Secreted Wild-type and Cma P → A Mutants </plain></SENT>
</text></title><p><text><SENT sid="8081" pm="."><plain>Colicins, including Cma, are not secreted but are rather unspecifically released by partial lysis of the producing cells. Lysis is caused by a lysis protein that is not encoded on pColBM plasmids (26). </plain></SENT>
<SENT sid="8083" pm="."><plain>Therefore, 90% of the Cma stays inside cells. To examine whether Cma translocated across the outer membrane only requires FkpA or whether Cma secreted across the cytoplasmic membrane also requires FkpA, we fused wild-type and mutant Cma proteins to the signal sequence of the periplasmic MalE-binding protein. In a previous paper of our laboratory (34) Cma was fused to the signal peptide of the murein lipoprotein and killed cells of fhuA, tonB, and exbBD uptake mutants but left a tolM, now designated fkpA, mutant unaffected. The Cma constructs chosen in this paper contained the MalE signal peptide for secretion and C-terminal His6 for purification and are designated as secreted Cma (Cmasec). </plain></SENT>
<SENT sid="8087" pm="."><plain>We cloned the fusion gene downstream of the araC arabinose promoter, which tightly controls transcription of downstream genes. This was important for cloning as uninduced transcription might have resulted in cell lysis and failure to obtain transformants. In addition, the level of expression can be modulated over a wide range (up to 1200-fold) depending on the concentration of the arabinose inducer (35). </plain></SENT>
<SENT sid="8090" pm="."><plain>Cmasec transformants grew well in the uninduced state and stopped growing upon induction of cmasec transcription with 0.1% arabinose. Growth inhibition could be caused by the phosphatase activity of Cma or by Cma jamming the secretion pathway by folding in the cytoplasm before secretion, as has for example been shown for the outer membrane LamB protein fused to a large C-terminal fragment of β-galactosidase. In this case cells become sensitive to induction by maltose as enhanced synthesis of the LamB-LacZ hybrid protein impairs secretion of LamB-LacZ and of other proteins (36). </plain></SENT>
<SENT sid="8093" pm="."><plain>Indeed, 0.1% arabinose inhibited not only the growth of cells that synthesized wild-type Cmasec but also of cells that synthesized inactive mutant Cmasec(D226A) (data not shown). </plain></SENT>
<SENT sid="8094" pm="."><plain>Asp-226 is located in the predicted active center of Cma and is essential for Cma activity (8, 9, 29). </plain></SENT>
<SENT sid="8095" pm="."><plain>At an arabinose concentration of 0.001%, Cma(D226A) did not inhibit growth, but wild-type Cma and Cma(P107A), with 10% activity in the plate test, completely inhibited growth and lysed cells (Fig. 4A). </plain></SENT>
<SENT sid="8096" pm="."><plain>Cma(P129A), Cma(P176A), and Cma(P260A) displayed residual activities, with Cma(P176A) having the lowest. To compare growth inhibition of wild-type with an fkpA mutant, we increased the level of the Cma mutant proteins by enhancing transcription with a higher arabinose concentration (0.01%). </plain></SENT>
<SENT sid="8098" pm="."><plain>At this concentration, Cma(D226A) failed to inhibit growth (Fig. 4B), which indicated that growth inhibition by interference with protein secretion played no role. The Cma P → A mutant proteins now inhibited growth, which was abolished in the fkpA strain. Regardless of whether Cma and its mutant derivatives were imported across the outer membrane or secreted across the cytoplasmic membrane, they required FkpA to be active in the periplasm. <SecTag type="FIG"><fig id="F4" position="float"><label>FIGURE 4.</label><caption><p><text><SENT sid="8101" pm="."><plain>Growth inhibition and lysis of E. coli Mo3 fkpA (filled symbols) and E. coli MB97 fhuA (open symbols) by Cma and its mutant derivatives fused to the MalE signal sequence after induction of Cma synthesis by 0.001% arabinose (A) and 0.01% arabinose (B). Samples were withdrawn at the indicated times, and the optical density (OD) was measured at 578 nm. </caption><graphic xlink:href="zbc0111151010004"/></fig></SecTag></sec><sec><title><text><SENT sid="8102" pm="."><plain>Catalysis of Prolyl Cis-Trans Isomerization of the Phe-Pro-176 Bond by FkpA </plain></SENT>
</text></title><p><text><SENT sid="8103" pm="."><plain>Cma(P176A) shocked into the periplasm had a 10-fold lower activity than the other Cma P → A mutants. This residual activity was independent of FkpA, which suggested that the replacement of Pro-176 by alanine affected interaction with FkpA. The Phe-Ala-176 bond is not a substrate of FkpA since FkpA-type PPIases do not catalyze cis-trans isomerization of nonprolyl peptide bonds (37). </plain></SENT>
<SENT sid="8106" pm="."><plain>To test whether the Phe-Pro-176 bond serves as a substrate for the FkpA PPIase, we used a novel peptide assay. Disulfide-constrained synthetic pentapeptide derivatives of the amino acid sequence p-aminobenzoyl-Cys-Xaa-Pro-Yaa-Cys-(NO2)Tyr-NH2 exhibit a high content of Xaa-Pro cis conformation (38). </plain></SENT>
<SENT sid="8108" pm="."><plain>Upon opening of the disulfide bridge by reduction, the cis/trans ratio declines to an open-chain cis isomer level of ∼15% (39). </plain></SENT>
<SENT sid="8109" pm="."><plain>Only in the cis conformation is the fluorescence of the p-aminobenzoyl group efficiently quenched by the nitrotyrosine amide. After reduction of the disulfide bridge, fluorescence increases during cis/trans interconversion of the Xaa-Pro bond. This slow reaction is accelerated by PPIases, which use the peptides as substrates. <p><text><SENT sid="8112" pm="."><plain>We compared spontaneous and FkpA-catalyzed cis-trans isomerization of the substrate p-aminobenzoyl-CFPVC-(NO2)Tyr-NH2, which represents the amino acid sequence adjacent to Cma Phe-Pro-176-Val, and used as controls p-aminobenzoyl-CKPAC-(NO2)Tyr-NH2 and p-aminobenzoyl-CLPGC-(NO2)Tyr-NH2, which represent the amino acid sequences adjacent to Cma Lys-Pro-107-Ala and Cma Leu-Pro-260-Gly, respectively. FkpA was purified to electrophoretic homogeneity by Ni-NTA-agarose chromatography and subsequent gel filtration on a Superdex 75 column. FkpA considerably accelerated cis-trans isomerization of the prolyl bond in Phe-Pro-176-Val as compared with uncatalyzed spontaneous cis-trans isomerization (Fig. 5). </plain></SENT>
<SENT sid="8115" pm="."><plain>The kcat/Km value of the catalyzed reaction was similar to the kcat/Km values of FKBP-type PPIases with optimal substrates (40). </plain></SENT>
<SENT sid="8116" pm="."><plain>The kcat/Km value was 14- and 12-fold more efficient than the kcat/Km values of the Lys-Pro-107-Ala and Leu-Pro-260-Gly peptides, respectively (Fig. 6, Table 5). </plain></SENT>
<SENT sid="8117" pm="."><plain>The low value of the Lys-Pro-107-Ala peptide is particularly interesting because it indicates that the only cis prolyl bond in Cma is unlikely to be the site of FkpA cis-trans isomerization. <SecTag type="FIG"><fig id="F5" position="float"><label>FIGURE 5.</label><caption><p><text><SENT sid="8118" pm="."><plain>Time-dependent spontaneous cis-trans isomerization of peptide p-aminobenzoyl-CFPVC-(NO2)Tyr-NH2 (lower curve) and FkpA-catalyzed cis-trans isomerization of peptide p-aminobenzoyl-CFPVC-(NO2)Tyr-NH2 (upper curve) after reduction of the disulfide bond with DDT. </caption><graphic xlink:href="zbc0111151010005"/></fig></SecTag><SecTag type="FIG"><fig id="F6" position="float"><label>FIGURE 6.</label><caption><p><text><SENT sid="8119" pm="."><plain>Determination of kcat/Km of FkpA-catalyzed cis-trans isomerization of the Phe-Pro-176 bond in p-aminobenzoyl-CFPVC-(NO2)Tyr-NH2, the Lys-Pro-107 bond in p-aminobenzoyl-CKPAC-(NO2)Tyr-NH2, and the Leu-Pro-260 bond in p-aminobenzoyl-CLPGC-(NO2)Tyr-NH2 by measuring the linear dependence of kenz on the concentration of FkpA. </caption><graphic xlink:href="zbc0111151010006"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="T5" position="float"><label>TABLE 5</label><caption><p><text><SENT sid="8120" pm="."><plain>Catalysis of prolyl cis-trans isomerization of Cma peptides by FkpA, FkpA43, and FkpA313 <p><text><SENT sid="8121" pm="."><plain>ND, not determined. </caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1"><text><SENT sid="8122" pm="."><plain>Cma prolyl bond </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8123" pm="."><plain>Kcat/Km FkpA </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8124" pm="."><plain>Kcat/Km FkpA43 </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="8125" pm="."><plain>Kcat/Km FkpA313 </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><text><SENT sid="8126" pm="."><plain>m−1s−1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="8127" pm="."><plain>m−1s−1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="8128" pm="."><plain>m−1s−1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8129" pm="."><plain>Phe-Pro-176 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8130" pm="."><plain>(1.38 ± 0.12) × 106 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8131" pm="."><plain>(6.61 ± 0.33) × 105 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8132" pm="."><plain>(3.45 ± 0.43) × 103 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8133" pm="."><plain>Leu-Pro-260 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8134" pm="."><plain>(1.15 ± 0.11) × 105 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8135" pm="."><plain>(1.34 ± 0.17) × 105 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8136" pm="."><plain>(5.11 ± 1.44) × 103 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="8137" pm="."><plain>Lys-Pro-107 </plain></SENT>
</text></td><td align="char" char="±" rowspan="1" colspan="1"><text><SENT sid="8138" pm="."><plain>(9.69 ± 0.67) × 104 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8139" pm="."><plain>ND </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="8140" pm="."><plain>ND </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="8141" pm="."><plain>To further support the role of FkpA PPIase activity for Cma activity, we determined the catalytic efficiency toward the Phe-Pro-176-Val and Leu-Pro-260-Gly derivatives using the FkpA313 mutant protein, which contains a G148D replacement in the PPIase domain and does not mediate Cma sensitivity to cells (11). </plain></SENT>
<SENT sid="8142" pm="."><plain>Only a very low in vitro PPIase activity of FkpA313 was observed with both peptides; the activity amounted to 0.4 and 0.2% that of wild-type FkpA (Table 5). </plain></SENT>
<SENT sid="8143" pm="."><plain>The data were further corroborated by the temperature-sensitive mutant FkpA43, which confers 10% activity to Cma at 30 °C and no activity at 42 °C (11). </plain></SENT>
<SENT sid="8144" pm="."><plain>It displayed a 2-fold lower PPIase activity than wild-type FkpA for Phe-Pro-176-Val and a 5-fold lower activity for Leu-Pro-260-Gly than for Phe-Pro-176-Val (measured at 10 °C) (Table 5). </plain></SENT>
<SENT sid="8145" pm="."><plain>The near inactivity of mutant Cma(P176A) in lysing cells and the high efficiency of FkpA in the catalysis of the cis-trans isomerization of Phe-Pro-176-Val peptide suggest that Phe-Pro-176 is the Cma peptide bond that is most likely catalytically cis-trans isomerized by FkpA. </sec></sec></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion"><title><text><SENT sid="8146" pm="."><plain>DISCUSSION </plain></SENT>
</text></title><p><text><SENT sid="8147" pm="."><plain>Periplasmic folding helper proteins interact with outer membrane proteins, and a considerable degree of redundancy and overlap in their function is observed (41–49). </plain></SENT>
<SENT sid="8148" pm="."><plain>For the periplasmic PPIases FkpA, PpiA, PpiD, and SurA of E. coli, no specificity for a distinct protein has been found, and no defined prolyl bond of a bacterial protein cis-trans isomerized by a PPIase has been identified yet. The strict dependence of Cma toxicity on FkpA allowed us to search for a correlation between Cma activity and FkpA catalysis of cis-trans isomerization of a specific prolyl bond of Cma. Using such an approach, we could identify a critical prolyl bond of Cma. <p><text><SENT sid="8151" pm="."><plain>The 15 Cma proline-to-alanine replacement mutants encompassed all proline residues in Cma. Three mutants showed a strongly reduced (1%) killing of E. coli. A fourth mutant, Cma(P107A), had 10% of Cma wild-type activity in plate assays. This mutant was interesting because Pro-107 forms the only prolyl cis peptide bond in Cma. Strongly increased activity after bypassing the energy-coupled uptake by osmotic shock suggested that three mutant proteins (Cma(P107A), Cma(P129A), and Cma(P260A)) were impaired in uptake. Indeed, Cma(P129A) did not bind to the FhuA receptor. The translocation efficiency of Cma(P107A) was probably affected by the isomerization of the Lys-Pro cis bond to a Lys-Ala trans bond even though this conversion altered the protein crystal structure only locally. Because the molecular mechanism of Cma translocation and in fact of any colicin across the outer membrane is unknown, it is not clear to what extent regions other than the translocation domain (residues 1–35) contribute to uptake across the outer membrane. The same reasoning applies to Cma(P260A), whose mutation is not located in the translocation domain but, rather, in the activity domain. <p><text><SENT sid="8160" pm="."><plain>Cma(P176A) was the only mutant with very low activity (1%) that remained nearly inactive when it was osmotically shocked into cells. It also displayed the lowest activity when it was equipped with a signal sequence, which allowed it to be secreted from the cytoplasm into the periplasm. Because the crystal structure of Cma(P176A) did not differ from the crystal structure of wild-type Cma, it is unlikely that the mutation affects the active center of Cma(P176A). </plain></SENT>
<SENT sid="8163" pm="."><plain>Pro-176 is exposed at the Cma surface (Fig. 1) and its conversion to A176 does not change the Cma structure beyond the mutation site. <p><text><SENT sid="8164" pm="."><plain>Previous results indicate that Pro-176 is not in the active site of Cma (8, 9, 29). </plain></SENT>
<SENT sid="8165" pm="."><plain>Random and site-directed mutagenesis of cma localized the active center around residue D226, a strictly conserved residue in a region in which the Cma-type sequences display the highest level of identity (8, 9). </plain></SENT>
<SENT sid="8166" pm="."><plain>Pro-176 is located far from Asp-226 (Fig. 1). </plain></SENT>
<SENT sid="8167" pm="."><plain>If the P176A mutation affects Cma activity independent of catalysis by FkpA, the mutation must have a long distance structural effect on the active center; such an effect was not observed in the crystal structure. We also found no evidence for a structural alteration of Cma(P176A) in solution; it acted like wild-type Cma with regard to proteinase K digestion, thermal denaturation, and urea denaturation. <p><text><SENT sid="8169" pm="."><plain>FkpA exhibits PPIase and chaperone activities with artificial substrates (13, 15, 16). </plain></SENT>
<SENT sid="8170" pm="."><plain>FkpA reactivates Cma denatured with 5 m guanidine hydrochloride, which is inhibited by FK506 (11), an inhibitor of the PPIase activity. In addition, the G148D mutation in the FkpA PPIase center abolishes Cma renaturation (11) and confers resistance to Cma. Additional mutants in the PPIase domain and only in the PPIase domain, G176D and G180D, were isolated by independent random mutagenesis, which did not confer Cma sensitivity.3 Arié et al. (13) isolated by site-specific mutagenesis FkpA mutants I174S and I174S/G176S and found no or only 5% PPIase activity but unaltered chaperone activity using a standard protease-coupled peptide assay. These mutants strongly favor the PPIase activity in Cma activation. In this study Phe-Pro-176 is the only bond left for cis-trans isomerization. The high catalytic efficiency of FkpA toward the Phe-Pro-176 peptide substrate, which was 14- and 12-fold higher than toward the Lys-Pro-107 and Leu-Pro-260 peptide substrates agrees with this proposal. <p><text><SENT sid="8176" pm="."><plain>Pro-176 is exposed at the surface of Cma (Fig. 1) and can, thus, be approached by FkpA. Pro-107 and -260 are also close to the surface but are less exposed than Pro-176. </plain></SENT>
<SENT sid="8178" pm="."><plain>Pro-129 is buried inside Cma and cannot be reached by FkpA unless strong structural alterations are induced by binding of Cma to FkpA before catalysis of cis-trans isomerization. The location of the Phe-Pro-176 bond makes it the most likely candidate for cis-trans isomerization. <p><text><SENT sid="8180" pm="."><plain>Despite strong evidence for the PPIase activity of FkpA in Cma activation, its chaperone activity should also be considered. Cma(P176A) transferred into the periplasm by osmotic shock did not respond to FkpA as the residual activity was not altered in the fkpA deletion mutant (Table 4). </plain></SENT>
<SENT sid="8182" pm="."><plain>However, Cma(P176A) secreted from the cytoplasm into the periplasm by a signal sequence fused to Cma(P176A) stopped growth of the fkpA wild-type cells and failed to stop growth of the fkpA mutant. Although this activity was weak and was only observed after increased synthesis of Cma(P176A), it nevertheless demonstrates some response of Cma(P176A) to FkpA. We assign this activity to the chaperone function of FkpA in the periplasm. However, an exclusive FkpA chaperone activity for activation of Cma would not show such a high site specificity as found for the inactive point mutants in the PPIase domain. <p><text><SENT sid="8186" pm="."><plain>Cma must unfold at least partially during translocation across the outer membrane and, when fused to a signal sequence, during translocation across the cytoplasmic membrane. Unfolding may convert the Phe-Pro-176 trans bond into a cis bond. Trans to cis isomerization also occurred in Cma mutant proteins in which Pro-176 was replaced by Ala, Gly, Leu, Val, Thr, Lys, and Asp. These derivatives were all inactive or nearly inactive because the lack of Pro prevented FkpA-catalized cis to trans isomerization during refolding in the periplasm. The conversion involves the PPIase, but the chaperone function of FkpA also contributes to Cma activation. Direct determination of the cis to trans conversion is hampered by the few molecules of Cma in the periplasm, which are sufficient to kill cells (20) and the much larger unspecific adsorption of Cma to the cells. In addition, we found no suitable wavelength at which fluorescence changes reflected structural changes during in vitro refolding of denatured Cma by FkpA (11). </plain></SENT>
<SENT sid="8192" pm="."><plain>Cma refolding may contribute energy for translocation. In addition, FkpA may act as a chaperone that binds imported Cma and prevents proteolytic degradation of the unfolded protein. Multiple functions of FkpA (Cma refolding, binding of Cma in the periplasm, and positioning of Cma to the substrate site) best explain the complete dependence of Cma activity on FkpA. </sec></SecTag>
      <SecTag type="SUPPL"><sec sec-type="supplementary-material">
         <title><text><SENT sid="8195" pm="."><plain>Supplementary Material </plain></SENT>
</text></title>
         <supplementary-material id="PMC_1" content-type="local-data">
            <caption>
               <title><text><SENT sid="8196" pm="."><plain>Supplemental Data </plain></SENT>
</text></title>
            </caption>
            <media mimetype="text" mime-subtype="html" xlink:href="supp_286_8_6280__index.html"/>
            <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_M110.165274_jbc.M110.165274-1.pdf"/>
         </supplementary-material>
      </sec></SecTag>
   </body><back><fn-group><SecTag type="ACK_FUND"><fn fn-type="supported-by" id="FN1"><label>*</label><p><text4fund><text><SENT sid="8197" pm="."><plain>This work was supported by the Max Planck Society, the German Science Foundation (BR 30/25-1), and the Fonds der Chemischen Industrie. </p></fn></SecTag><SecTag type="SUPPL"><fn fn-type="supplementary-material" id="FN2"><label><inline-graphic xlink:href="sbox.jpg"/></label><p><text><SENT sid="8198" pm="."><plain>The on-line version of this article (available at <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org">http://www.jbc.org</ext-link>) contains <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M110.165274/DC1">supplemental Figs. S1–S4</ext-link>. </fn></SecTag><fn fn-type="other"><p><text><SENT sid="8199" pm="."><plain>The atomic coordinates and structure factors (codes <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=2XMX">2XMX</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=2XTR">2XTR</ext-link>) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/">http://www.rcsb.org/</ext-link>). </fn><fn fn-type="other" id="FN4"><label>3</label><p><text><SENT sid="8200" pm="."><plain>S. I. Patzer, unpublished results. </fn></fn-group><fn-group content-type="abbreviations"><fn id="FN3"><label>2</label><p><text><SENT sid="8203" pm="."><plain>The abbreviations used are: Cmacolicin MPPIasepeptidyl prolyl cis-trans isomeraseNi-NTAnickel-nitrilotriacetic acidBis/Tris2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diolFKBPFK506-binding protein. </fn></fn-group><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="8204" pm="."><plain>We thank Dr. Reinhard Albrecht and Kerstin Bär for valuable help in protein crystallization, Dr. Andrei Lupas for generous support, and Karen A. Brune for critically reading the manuscript. We cordially thank the beamline staff from the Max Planck beamline PX10 at the Swiss Light Source for great help and beamline maintenance. </p></ack></SecTag><SecTag type="REF"><ref-list><title>REFERENCES</title><ref id="B1"><text><SENT sid="8207" pm="."><plain>1. SchallerK.HöltjeJ. V.BraunV. (1982) J. Bacteriol. 152, 994–1000 6754708 </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="8210" pm="."><plain>2. HarknessR. E.BraunV. (1989) J. Biol. Chem. 264, 6177–6182 2649496 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="8214" pm="."><plain>3. El GhachiM.BouhssA.BarreteauH.TouzéT.AugerG.BlanotD.Mengin-LecreulxD. (2006) J. Biol. Chem. 281, 22761–22772 16777846 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="8217" pm="."><plain>4. BraunV. (1995) FEMS Microbiol. Rev. 16, 295–307 7654405 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="8219" pm="."><plain>5. BraunV.PatzerS. I.HantkeK. (2002) Biochimie 84, 365–380 12423780 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="8221" pm="."><plain>6. PostleK.LarsenR. A. (2007) Biometals 20, 453–465 17225934 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="8223" pm="."><plain>7. DreherR.BraunV.Wittmann-LieboldB. (1985) Arch. Microbiol. 140, 343–346 3985748 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="8225" pm="."><plain>8. ZethK.RömerC.PatzerS. I.BraunV. (2008) J. Biol. Chem. 283, 25324–25331 18640984 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="8229" pm="."><plain>9. BarreteauH.BouhssA.GérardF.DuchéD.BoussaidB.BlanotD.LloubèsR.Mengin-LecreulxD.TouzéT. (2010) J. Biol. Chem. 285, 12378–12389 20159977 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="8232" pm="."><plain>10. BraunV.FrenzJ.HantkeK.SchallerK. (1980) J. Bacteriol. 142, 162–168 6989802 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="8234" pm="."><plain>11. HullmannJ.PatzerS. I.RömerC.HantkeK.BraunV. (2008) Mol. Microbiol. 69, 926–937 18554332 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="8237" pm="."><plain>12. DaneseP. N.SilhavyT. J. (1997) Genes Dev. 11, 1183–1193 9159399 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="8240" pm="."><plain>13. AriéJ. P.SassoonN.BettonJ. M. (2001) Mol. Microbiol. 39, 199–210 11123702 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="8244" pm="."><plain>14. BothmannH.PluckthunA. (2000) J. Biol. Chem. 275, 17100–17105 10748200 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="8247" pm="."><plain>15. RammK.PlückthunA. (2001) J. Mol. Biol. 310, 485–498 11428902 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="8250" pm="."><plain>16. SaulF. A.AriéJ. P.Vulliez-le NormandB.KahnR.BettonJ. M.BentleyG. A. (2004) J. Mol. Biol. 335, 595–608 14672666 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="8257" pm="."><plain>17. BettonJ. M. (2007) in The Periplasm (EhrmannM. ed) pp. 141–149, American Society for Microbiology, Washington, D. C </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="8260" pm="."><plain>18. KleinschmidtJ. H. (2007) in The Periplasm (EhrmannM. ed) pp. 30–66, American Society for Microbiology, Washington, D. C </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="8263" pm="."><plain>19. MogensenJ. E.OtzenD. E. (2005) Mol. Microbiol. 57, 326–346 15978068 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="8267" pm="."><plain>20. SchallerK.DreherR.BraunV. (1981) J. Bacteriol. 146, 54–63 7012126 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="8269" pm="."><plain>21. KabschW. (2010) Acta. Crystallogr. D Biol. Crystallogr. 66b, 125–13220124692 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="8273" pm="."><plain>22. PottertonE.BriggsP.TurkenburgM.DodsonE. (2003) Acta. Crystallogr. D Biol. Crystallogr. 59, 1131–1137 12832755 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="8277" pm="."><plain>23. EmsleyP.CowtanK. (2004) Acta. Crystallogr. D Biol. Crystallogr. 60, 2126–2132 15572765 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="8281" pm="."><plain>24. LaskowskiR. A.MossD. S.ThorntonJ. M. (1993) J. Mol. Biol. 231, 1049–1067 8515464 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="8287" pm="."><plain>25. KabschW.SanderC. (1983) Biopolymers 22, 2577–2637 6667333 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="8288" pm="."><plain>26. ThummG.OlschlägerT.BraunV. (1988) Plasmid 20, 75–82 2853881 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="8289" pm="."><plain>27. NossalN. G.HeppelL. A. (1966) J. Biol. Chem. 241, 3055–3062 4287907 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="8294" pm="."><plain>28. TilbyM.HindennachI.HenningU. (1978) J. Bacteriol. 136, 1189–1191 363693 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="8296" pm="."><plain>29. PilslH.GlaserC.GrossP.KillmannH.OlschlägerT.BraunV. (1993) Mol. Gen. Genet. 240, 103–112 8341256 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="8299" pm="."><plain>30. KadnerR. J.HellerK. J. (1995) J. Bacteriol. 177, 4829–4935 7665457 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="8303" pm="."><plain>31. HarknessR. E.BraunV. (1990) Mol. Gen. Genet. 222, 37–40 2233679 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="8307" pm="."><plain>32. OlschlägerT.TurbaA.BraunV. (1991) Mol. Microbiol. 5, 1105–1111 1956288 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="8309" pm="."><plain>33. GrossP.BraunV. (1996) Mol. Gen. Genet. 251, 388–396 8676883 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="8312" pm="."><plain>34. OlschlägerT. (1991) Arch. Microbiol. 156, 449–454 1785952 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="8314" pm="."><plain>35. GuzmanL. M.BelinD.CarsonM. J.BeckwithJ. (1995) J. Bacteriol. 177, 4121–4130 7608087 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="8318" pm="."><plain>36. BensonS. A.BremerE.SilhavyT. J. (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 3830–3834 6374667 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="8325" pm="."><plain>37. Schiene-FischerC.HabazettlJ.SchmidF. X.FischerG. (2002) Nat. Struct. Biol. 9, 419–424 12021775 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="8329" pm="."><plain>38. FischerG.AumüllerT. (2003) Rev. Physiol. Biochem. Pharmacol. 148, 105–150 12698322 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="8333" pm="."><plain>39. WeisshoffH.FrostK.BrandtW.HenkleinP.MüggeC.FrömmelC. (1995) FEBS Lett. 372, 203–209 7556670 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="8334" pm="."><plain>40. HarrisonR. K.SteinR. L. (1990) Biochemistry 29, 3813–3816 1693856 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="8337" pm="."><plain>41. ChenR.HenningU. (1996) Mol. Microbiol. 19, 1287–1294 8730870 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="8339" pm="."><plain>42. JusticeS. S.HunstadD. A.HarperJ. R.DuguayA. R.PinknerJ. S.BannJ.FriedenC.SilhavyT. J.HultgrenS. J. (2005) J. Bacteriol. 187, 7680–7686 16267292 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="8348" pm="."><plain>43. QuJ.MayerC.BehrensS.HolstO.KleinschmidtJ. H. (2007) J. Mol. Biol. 374, 91–105 17928002 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="8352" pm="."><plain>44. RizzitelloA. E.HarperJ. R.SilhavyT. J. (2001) J. Bacteriol. 183, 6794–6800 11698367 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="8357" pm="."><plain>45. RouvièreP. E.GrossC. A. (1996) Genes Dev. 10, 3170–3182 8985185 </plain></SENT>
</text></ref><ref id="B46"><text><SENT sid="8360" pm="."><plain>46. SchäferU.BeckK.MüllerM. (1999) J. Biol. Chem. 274, 24567–24574 10455120 </plain></SENT>
</text></ref><ref id="B47"><text><SENT sid="8363" pm="."><plain>47. SklarJ. G.WuT.KahneD.SilhavyT. J. (2007) Genes Dev. 21, 2473–2484 17908933 </plain></SENT>
</text></ref><ref id="B48"><text><SENT sid="8366" pm="."><plain>48. StymestK. H.KlappaP. (2008) FEBS 275, 3470–3479  </plain></SENT>
</text></ref><ref id="B49"><text><SENT sid="8368" pm="."><plain>49. VertommenD.RuizN.LeverrierP.SilhavyT. J.ColletJ. F. (2009) Proteomics 9, 2432–2443 19343722 </plain></SENT>
</text></ref><ref id="B50"><text><SENT sid="8371" pm="."><plain>50. StudierF. W.MoffattB. A. (1986) J. Mol. Biol. 189, 113–130 3537305 </plain></SENT>
</text></ref><ref id="B51"><text><SENT sid="8376" pm="."><plain>51. MendeJ.BraunV. (1990) Mol. Microbiol. 4, 1523–1533 2287276 </plain></SENT>
</text></ref><ref id="B52"><text><SENT sid="8378" pm="."><plain>52. HanahanD. (1983) J. Mol. Biol. 166, 557–580 6345791 </plain></SENT>
</text></ref><ref id="B53"><text><SENT sid="8381" pm="."><plain>53. TaborS.RichardsonC. C. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 1074–1078 3156376 </plain></SENT>
</text></ref><ref id="B54"><text><SENT sid="8387" pm="."><plain>54. BraunM.EndrissF.KillmannH.BraunV. (2003) J. Bacteriol. 185, 5508–551812949103 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
